Summary
329.78
2.67
(0.82%)
07/10/2026
Stryker Corporation (SYK)Key Facts
Performance
Historical returns1D
0.82%
1W
1.56%
1M
7.06%
3M
-2.50%
6M
-8.25%
1Y
-15.61%
5Y
31.11%
Snapshot
Key statisticsClose
329.78
Change
2.67
Change %
0.82%
Open
328.06
Day Range
327.00 – 331.58
Volume
2,069,257
Avg Vol (20d)
2,658,172
Rel Vol
0.78x
52W Range
280.25 - 400.78
vs 52W High
-17.72%
vs 52W Low
17.67%
Gap
-2.16
Market Cap
USD 135.35B
Beta
0.90
Dividend Yield
0.95%
Price Chart
Advanced chartCompareLast 730 data points are shown. To view all data, Upgrade to PRO plan!
Financial SnapshotFY 2025
Full financialsRevenue
USD 25.12B
+11.2% YoY
Net Income
USD 3.25B
+8.5% YoY
EPS
8.49
+8.0% YoY
Gross Margin
64.0%
Operating Margin
19.5%
Net Margin
12.9%
EBITDA
USD 6.31B
Free Cash Flow
USD 4.28B
17.1% margin
ROE
14.5%
ROA
6.8%
Debt / Equity
0.66x
net debt USD 10.85B
Cash & Equiv.
USD 4.01B
Fundamental Ratings
MainB
RecommendedNeutral
DCFBuy
ROEBuy
ROABuy
Debt/EquityStrong Sell
P/EStrong Sell
P/BSell
Latest Earnings
- SYK reported last earnings on 2026-04-30.
- EPS of $2.6 vs $2.98 estimated — surprise $-0.38.
- Revenue of $6,020M vs $6,337M estimated — surprise $-317M.
News
All newsStryker: The Market Is Overreacting To One Disrupted Quarter
Stryker remains a high-quality MedTech compounder despite a rare Q1 miss driven by a temporary cyber disruption. Q1 weakness was not demand-driven; full-year guidance is unchanged and end-market demand remains healthy. Current valuation reflects temporary disruption, offering a more attractive...
Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs
Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Stryker: Medtech On Sale, Benefiting From Industry Growth
Stryker Corporation offers a compelling medtech investment, benefiting from robust industry growth and an innovation-led strategy. SYK trades at a 13% discount to fair value, with a forward P/E of 20.1 versus a 10-year average of 25.6. Consensus expects SYK's adjusted diluted EPS to compound at...
Buy these quality, low-stress stocks for the summer, says Jefferies
Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending. The S&P 500 momentum index has outperformed the wider market by more than 70% since 2024, close to levels seen during the 1990s dot-com era.
Stryker: The Reshaped Product Portfolio Will Drive Growth
Stryker is a Dividend Aristocrat with 32 years of increases, robust cash flow, and a strong M&A-driven growth strategy. SYK's Q1 2026 results were impacted by a cybersecurity incident, but management maintained full-year guidance and expects normalization. The stock trades at ~21x 2026E EPS, below...
Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation
Stryker (NYSE:SYK | SYK Price Prediction) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results.
Stryker to announce second quarter 2026 financial results
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.
Stryker Corp (SYK) Stock Down 4.7% -- Now Undervalued? GF Score: 92/100
On June 30, 2026, Stryker Corp (SYK) shares fell 4.7% to a current price of $314.84. This decline comes in a challenging year where the stock has seen a year-to
Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?
Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand...
PAHC vs. SYK: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Vistra Corp. (NYSE:VST), adding it “went too high. It's come back down.
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.
Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures
SYK launches TPX HD, a small bone power tool built for complex revisions, MIS and oral maxillofacial cases with higher torque and speed.
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
PORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total...
Is SYK Overvalued? DCF Says Worth $206
On June 02, 2026, we present a DCF analysis for Stryker Corp (SYK) amidst its recent price performance, which has seen a decline of 14.6% year-to-date and 21.0%
Stryker Launches Pangea Plating System in Europe for Fracture Fixation
SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.
Stryker Launches Pangea Plating System and Completes First Case in Europe
Stryker (NYSE: SYK), a global leader in medical technologies, announced today the European launch of its [url="]Pangea Plating System[/url], a plating platform